DORMAN PRODUCTS INC (DORM) Fundamental Analysis & Valuation

NASDAQ:DORM • US2582781009

Current stock price

105.925 USD
-0.55 (-0.51%)
Last:

This DORM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. DORM Profitability Analysis

1.1 Basic Checks

  • DORM had positive earnings in the past year.
  • DORM had a positive operating cash flow in the past year.
  • In the past 5 years DORM has always been profitable.
  • In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • The Return On Assets of DORM (8.19%) is better than 87.80% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.82%, DORM belongs to the top of the industry, outperforming 87.80% of the companies in the same industry.
  • DORM has a Return On Invested Capital of 13.20%. This is amongst the best in the industry. DORM outperforms 90.24% of its industry peers.
  • DORM had an Average Return On Invested Capital over the past 3 years of 11.36%. This is above the industry average of 9.26%.
  • The 3 year average ROIC (11.36%) for DORM is below the current ROIC(13.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROIC 13.2%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • DORM has a Profit Margin of 9.59%. This is amongst the best in the industry. DORM outperforms 92.68% of its industry peers.
  • DORM's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 16.72%, DORM belongs to the top of the industry, outperforming 97.56% of the companies in the same industry.
  • DORM's Operating Margin has improved in the last couple of years.
  • DORM's Gross Margin of 42.14% is amongst the best of the industry. DORM outperforms 90.24% of its industry peers.
  • DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DORM Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DORM is creating some value.
  • The number of shares outstanding for DORM has been reduced compared to 1 year ago.
  • Compared to 5 years ago, DORM has less shares outstanding
  • Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 4.47 indicates that DORM is not in any danger for bankruptcy at the moment.
  • DORM's Altman-Z score of 4.47 is amongst the best of the industry. DORM outperforms 82.93% of its industry peers.
  • DORM has a debt to FCF ratio of 5.81. This is a neutral value as DORM would need 5.81 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 5.81, DORM is doing good in the industry, outperforming 60.98% of the companies in the same industry.
  • DORM has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • DORM's Debt to Equity ratio of 0.27 is fine compared to the rest of the industry. DORM outperforms 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Altman-Z 4.47
ROIC/WACC1.41
WACC9.37%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • A Current Ratio of 3.09 indicates that DORM has no problem at all paying its short term obligations.
  • The Current ratio of DORM (3.09) is better than 75.61% of its industry peers.
  • DORM has a Quick Ratio of 1.14. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of DORM (1.14) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 1.14
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DORM Growth Analysis

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.23%, which is quite impressive.
  • Measured over the past years, DORM shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.72% on average per year.
  • Looking at the last year, DORM shows a small growth in Revenue. The Revenue has grown by 6.03% in the last year.
  • The Revenue has been growing by 14.28% on average over the past years. This is quite good.
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%

3.2 Future

  • Based on estimates for the next years, DORM will show a small growth in Earnings Per Share. The EPS will grow by 6.46% on average per year.
  • The Revenue is expected to grow by 5.64% on average over the next years.
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. DORM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.94, which indicates a very decent valuation of DORM.
  • Based on the Price/Earnings ratio, DORM is valued a bit cheaper than 68.29% of the companies in the same industry.
  • DORM is valuated cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 11.83 indicates a reasonable valuation of DORM.
  • DORM's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of DORM to the average of the S&P500 Index (22.51), we can say DORM is valued slightly cheaper.
Industry RankSector Rank
PE 11.94
Fwd PE 11.83
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DORM is on the same level as its industry peers.
  • DORM's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 42.25
EV/EBITDA 8.75
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DORM does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)12.62
PEG (5Y)0.58
EPS Next 2Y5.42%
EPS Next 3Y-0.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DORM Dividend Analysis

5.1 Amount

  • DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DORM Fundamentals: All Metrics, Ratios and Statistics

DORMAN PRODUCTS INC

NASDAQ:DORM (3/27/2026, 10:31:56 AM)

105.925

-0.55 (-0.51%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners89.57%
Inst Owner Change0.85%
Ins Owners13.14%
Ins Owner Change2.74%
Market Cap3.20B
Revenue(TTM)2.13B
Net Income(TTM)204.19M
Analysts82.86
Price Target173.78 (64.06%)
Short Float %4.25%
Short Ratio4.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.11%
Min EPS beat(2)-0.69%
Max EPS beat(2)2.92%
EPS beat(4)3
Avg EPS beat(4)12.48%
Min EPS beat(4)-0.69%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)22.38%
EPS beat(12)8
Avg EPS beat(12)10.5%
EPS beat(16)9
Avg EPS beat(16)7.26%
Revenue beat(2)0
Avg Revenue beat(2)-5.69%
Min Revenue beat(2)-8.11%
Max Revenue beat(2)-3.26%
Revenue beat(4)2
Avg Revenue beat(4)-1.28%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.69%
PT rev (1m)0%
PT rev (3m)-1.8%
EPS NQ rev (1m)-23.21%
EPS NQ rev (3m)-23.21%
EPS NY rev (1m)-7.47%
EPS NY rev (3m)-7.06%
Revenue NQ rev (1m)-1.65%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)0.56%
Revenue NY rev (3m)0.47%
Valuation
Industry RankSector Rank
PE 11.94
Fwd PE 11.83
P/S 1.5
P/FCF 42.25
P/OCF 28.13
P/B 2.16
P/tB 3.84
EV/EBITDA 8.75
EPS(TTM)8.87
EY8.37%
EPS(NY)8.95
Fwd EY8.45%
FCF(TTM)2.51
FCFY2.37%
OCF(TTM)3.77
OCFY3.55%
SpS70.59
BVpS48.94
TBVpS27.59
PEG (NY)12.62
PEG (5Y)0.58
Graham Number98.83
Profitability
Industry RankSector Rank
ROA 8.19%
ROE 13.82%
ROCE 17.81%
ROIC 13.2%
ROICexc 13.54%
ROICexgc 20.22%
OM 16.72%
PM (TTM) 9.59%
GM 42.14%
FCFM 3.55%
ROA(3y)7.22%
ROA(5y)6.94%
ROE(3y)13.19%
ROE(5y)13.07%
ROIC(3y)11.36%
ROIC(5y)10.19%
ROICexc(3y)11.65%
ROICexc(5y)10.5%
ROICexgc(3y)18.73%
ROICexgc(5y)16.69%
ROCE(3y)15.58%
ROCE(5y)14.81%
ROICexgc growth 3Y20.29%
ROICexgc growth 5Y5.06%
ROICexc growth 3Y25.64%
ROICexc growth 5Y0.33%
OM growth 3Y19.24%
OM growth 5Y6.5%
PM growth 3Y11%
PM growth 5Y-0.41%
GM growth 3Y8.98%
GM growth 5Y3.75%
F-Score8
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 5.81
Debt/EBITDA 0.98
Cap/Depr 68.13%
Cap/Sales 1.78%
Interest Coverage 13.02
Cash Conversion 27.58%
Profit Quality 37.06%
Current Ratio 3.09
Quick Ratio 1.14
Altman-Z 4.47
F-Score8
WACC9.37%
ROIC/WACC1.41
Cap/Depr(3y)72.66%
Cap/Depr(5y)71.81%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.94%
Profit Quality(3y)88.47%
Profit Quality(5y)65.95%
High Growth Momentum
Growth
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue 1Y (TTM)6.03%
Revenue growth 3Y7.11%
Revenue growth 5Y14.28%
Sales Q2Q%0.78%
Revenue Next Year5.75%
Revenue Next 2Y5.33%
Revenue Next 3Y6%
Revenue Next 5Y5.64%
EBIT growth 1Y21.63%
EBIT growth 3Y27.72%
EBIT growth 5Y21.71%
EBIT Next Year14.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.51%
FCF growth 3Y171.04%
FCF growth 5Y-11.13%
OCF growth 1Y-50.82%
OCF growth 3Y39.68%
OCF growth 5Y-5.65%

DORMAN PRODUCTS INC / DORM Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 5 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


What is the profitability of DORM stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


Can you provide the financial health for DORM stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 7 / 10.


How sustainable is the dividend of DORMAN PRODUCTS INC (DORM) stock?

The dividend rating of DORMAN PRODUCTS INC (DORM) is 0 / 10 and the dividend payout ratio is 0%.